Dataset Information


Uncovering tumor intrinsic and extrinsic factors that regulate hepatocellular carcinoma growth using patient derived xenograft assays

ABSTRACT: Several major factors limit our understanding of hepatocellular carcinoma (HCC). First, human HCCs are infrequently biopsied for diagnosis and thus are not often biologically interrogated. Second, HCC initiation and progression are strongly influenced by the cirrhotic microenvironment, and the exact contributions of intrinsic and extrinsic tumor factors are unclear. A powerful approach to examine the personalized biology of liver cancers and the influence of host tissues is with patient derived xenograft (PDX) models. In Asia, HCCs from hepatitis B virus patients have been efficiently converted into PDXs, but few parallel efforts from the west have been reported. In a large-scale analysis, we implanted 93 HCCs and 8 cholangiocarcinomas (CCAs) to systematically analyze host factors and to define an optimized platform for PDX development from both surgical and biopsy samples. NSG mice that had undergone partial hepatectomy (PHx) represented the best combination of engraftability, growth, and passageability, but overall rates were low and indicative of a unique intrinsic biology for HCCs in the US. PDX models preserved the histology and genetic features of parental tumors, and ultimately, 9 new models were usable for pre-clinical studies. Intriguingly, HCC PDXs were differentially sensitive to regorafenib and sorafenib and CCA PDXs were also highly sensitive to regorafenib. PDX models functionalize early and advanced stage HCCs and revealed unique biological features of liver cancers from the US.

ORGANISM(S): Homo sapiens  

PROVIDER: EGAS00001004020 | EGA |


Similar Datasets

2019-01-01 | S-EPMC6646301 | BioStudies
2019-01-01 | S-EPMC6601318 | BioStudies
2020-01-01 | S-EPMC7646096 | BioStudies
2016-01-01 | S-EPMC5225101 | BioStudies
2014-01-01 | S-EPMC4062047 | BioStudies
1000-01-01 | S-EPMC6315895 | BioStudies
2013-01-01 | S-EPMC3881975 | BioStudies
2017-01-01 | S-EPMC5562363 | BioStudies
2019-01-01 | S-EPMC6587174 | BioStudies
1000-01-01 | S-EPMC5871898 | BioStudies